Labiotech.eu

News and Trends 25 Jun 2018

Update: Could Epigenetics Treat Alzheimer’s? A Spanish Biotech May Give Us Answers

Update (25/06/2018): Oryzon enrolls first patients in the UK in its clinical trial testing its epigenetic Alzheimer’s drug. The company plans to enroll a total of 90 patients in Spain, France and the UK. Update (14/05/2018): Oryzon has been given approval to expand to France its Phase IIa clinical trial for an epigenetic Alzheimer’s drug. The […]

June 25, 2018 - 3 minutesmins - By Alexander Burik

Interview 22 Jun 2018

Swedish Biotech’s Liquid Biopsy Could Improve Accuracy of Cancer Diagnoses

Elypta is developing liquid biopsies that analyze cancer metabolism to make cancer diagnoses more accurate. Philip talked to Francesco Gatto, Elypta’s Chief Scientific Officer and a co-founder, on their technology, moving from academia to industry, and the challenges of starting a biotech company. Even though biotechs and pharma companies across the globe have been pouring […]

June 22, 2018 - 5 minutesmins - By Alexander Burik

News and Trends 22 Jun 2018

Radiotherapy-Enhancing Cancer Nanomedicine Secures Good Phase II/III Results

A nanomedicine designed to help amplify and focus radiation treatment on hard to treat soft tissue sarcoma cells has achieved positive Phase II/III trial results for French-American biotech Nanobiotix. “Data are exceptional and show without any doubt an improvement of radiation therapy impact,” commented Sylvie Bonvalot, Head of Sarcoma and Complex Tumor Surgery Unit at […]

June 22, 2018 - 2 minutesmins - By Helen Albert

News and Trends 22 Jun 2018

Next-Generation CAR-T Company Raises €130M on NASDAQ IPO

London-based Autolus has made its debut on the NASDAQ raising funds to boost the development of a next generation of CAR-T cell therapy for cancer. Founded in 2014 as a spin-out from University College London, Autolus has been taking great strides to develop its CAR-T technology. In less than four years, the company managed to raise nearly €150M […]

June 22, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 21 Jun 2018

Gene Editing Could Cut the Cost of One of the Most Expensive Animal Diseases in the World

Researchers at the University of Edinburgh have genetically engineered pigs that are resistant to a common disease that has exorbitant costs to the livestock industry. Researchers at the University of Edinburgh, in collaboration with the animal genetics company Genus, have produced pigs that are resistant to one of the most costly animal diseases in the […]

June 21, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 20 Jun 2018

Massive Series B Funding Could Bring Belgian Immuno-oncology Treatments Into the Clinic

iTeos Therapeutics raised €65M ($75M) to bring two of its cancer treatments into the clinic within the next one and a half years. iTeos Therapeutics, a Belgian biotech, raised what may have been the largest Series B financing round in Europe so far this year, led by MPM Capital. The funding will be used to […]

June 20, 2018 - 2 minutesmins - By Alexander Burik

Gates Foundation Oxitec Malaria Genetically Modified Mosquitoes

News and Trends 20 Jun 2018

Gates Foundation and Oxitec Fight Malaria with Genetically-Modified Mosquitoes

The Bill & Melinda Gates Foundation has partnered with Oxitec for the development of a new strain of genetically-modified mosquitoes that can help reduce the spread of malaria in America. In its latest effort to free the world of malaria, the Bill & Melinda Gates Foundation has joined forces with Oxitec, a British company that […]

June 20, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 20 Jun 2018

“Have the guts to follow your instincts”: Top CEO Talks About His Time in Biotech

Some careers take on an international scope and span the breadth of big players in the pharmaceutical industry and small biotech startups. David Ebsworth, Chairman at Verona Pharma, can count his professional journey among these and gave us the inside scoop on the successes and challenges he faced, his perspective on European biotech, and advice to […]

June 20, 2018 - 9 minutesmins - By Alexander Burik

News and Trends 19 Jun 2018

A Chip Could Help Us Identify Wheeze-Causing Types of Viruses

Researchers in Vienna have developed a chip that identifies cold viruses that cause flare-ups of respiratory conditions such as asthma. The technology could help identify culprit viruses and help those affected take the best preventive and treatment measures. The chip, created by researchers at the Medical University of Vienna, uses a small blood sample to […]

June 19, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 19 Jun 2018

Biomaterial to Regenerate Teeth Approved in Europe

The Israeli company Datum Dental has received approval to launch a biomaterial for dental implants in Europe and Canada. Datum Dental has developed a biomaterial specifically designed to help the body regenerate real bone tissue after dental operations. Launched in the US last year, the biomaterial has now received CE marking in Europe and approval […]

June 19, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 19 Jun 2018

Bioprinting in Europe: Fact or Fiction?

A lot of fantasy surrounds bioprinting: everyone has in mind advanced reactors that would print, in just a few seconds or minutes, a missing body part or even a fully functioning organ. Still, as the technology gains in maturity, it’s no longer utopian to imagine tissue implants created from scratch. The bioprinting market is expected […]

June 19, 2018 - 3 minutesmins - By External Contributor

More News! 18 Jun 2018

Swiss Biotech Tackles Brain Artery Constriction Caused by Hemorrhage

Idorsia will start a Phase III trial to study the efficacy of its drug in treating the constriction of arteries in the brain caused by release of chemicals linked to a previous bleed in this area. The Swiss biotech Idorsia will test the efficacy of its drug, clazosentan, for treating patients whose brain arteries have […]

June 18, 2018 - 2 minutesmins - By Alexander Burik

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Update: Could Epigenetics Treat Alzheimer’s? A Spanish Biotech May Give Us Answers

Swedish Biotech’s Liquid Biopsy Could Improve Accuracy of Cancer Diagnoses

Radiotherapy-Enhancing Cancer Nanomedicine Secures Good Phase II/III Results

Next-Generation CAR-T Company Raises €130M on NASDAQ IPO

Gene Editing Could Cut the Cost of One of the Most Expensive Animal Diseases in the World

Massive Series B Funding Could Bring Belgian Immuno-oncology Treatments Into the Clinic

Gates Foundation and Oxitec Fight Malaria with Genetically-Modified Mosquitoes

“Have the guts to follow your instincts”: Top CEO Talks About His Time in Biotech

A Chip Could Help Us Identify Wheeze-Causing Types of Viruses

Biomaterial to Regenerate Teeth Approved in Europe

Bioprinting in Europe: Fact or Fiction?

Swiss Biotech Tackles Brain Artery Constriction Caused by Hemorrhage

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!